164 related articles for article (PubMed ID: 21638028)
1. Novel screening cascade identifies MKK4 as key kinase regulating Tau phosphorylation at Ser422.
Grueninger F; Bohrmann B; Christensen K; Graf M; Roth D; Czech C
Mol Cell Biochem; 2011 Nov; 357(1-2):199-207. PubMed ID: 21638028
[TBL] [Abstract][Full Text] [Related]
2. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
[TBL] [Abstract][Full Text] [Related]
4. Tau-tubulin kinase 1 expression, phosphorylation and co-localization with phospho-Ser422 tau in the Alzheimer's disease brain.
Lund H; Cowburn RF; Gustafsson E; Strömberg K; Svensson A; Dahllund L; Malinowsky D; Sunnemark D
Brain Pathol; 2013 Jul; 23(4):378-89. PubMed ID: 23088643
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibition induces stress kinase dependent transport deficits--implications for Alzheimer's disease.
Agholme L; Nath S; Domert J; Marcusson J; Kågedal K; Hallbeck M
Mol Cell Neurosci; 2014 Jan; 58():29-39. PubMed ID: 24270002
[TBL] [Abstract][Full Text] [Related]
6. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.
Cochran JN; Diggs PV; Nebane NM; Rasmussen L; White EL; Bostwick R; Maddry JA; Suto MJ; Roberson ED
J Biomol Screen; 2014 Dec; 19(10):1338-49. PubMed ID: 25156556
[TBL] [Abstract][Full Text] [Related]
7. [Phosphorylation of tau and Alzheimer's disease].
García T; Jay D
Gac Med Mex; 2004; 140(3):329-33. PubMed ID: 15259345
[TBL] [Abstract][Full Text] [Related]
8. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease.
Gu GJ; Wu D; Lund H; Sunnemark D; Kvist AJ; Milner R; Eckersley S; Nilsson LN; Agerman K; Landegren U; Kamali-Moghaddam M
J Alzheimers Dis; 2013; 33(3):699-713. PubMed ID: 23001711
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of serine 305 in tau inhibits aggregation.
Strang KH; Sorrentino ZA; Riffe CJ; Gorion KM; Vijayaraghavan N; Golde TE; Giasson BI
Neurosci Lett; 2019 Jan; 692():187-192. PubMed ID: 30423399
[TBL] [Abstract][Full Text] [Related]
10. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.
Drewes G; Trinczek B; Illenberger S; Biernat J; Schmitt-Ulms G; Meyer HE; Mandelkow EM; Mandelkow E
J Biol Chem; 1995 Mar; 270(13):7679-88. PubMed ID: 7706316
[TBL] [Abstract][Full Text] [Related]
11. Aβ monomer induces phosphorylation of Tau at Ser-214 through β2AR-PKA-JNK signaling pathway.
Wu H; Wei S; Huang Y; Chen L; Wang Y; Wu X; Zhang Z; Pei Y; Wang D
FASEB J; 2020 Apr; 34(4):5092-5105. PubMed ID: 32067279
[TBL] [Abstract][Full Text] [Related]
12. Targeting Tau Hyperphosphorylation
Turab Naqvi AA; Hasan GM; Hassan MI
Curr Top Med Chem; 2020; 20(12):1059-1073. PubMed ID: 31903881
[TBL] [Abstract][Full Text] [Related]
13. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
Coutadeur S; Benyamine H; Delalonde L; de Oliveira C; Leblond B; Foucourt A; Besson T; Casagrande AS; Taverne T; Girard A; Pando MP; Désiré L
J Neurochem; 2015 May; 133(3):440-51. PubMed ID: 25556849
[TBL] [Abstract][Full Text] [Related]
14. Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein.
Reynolds CH; Utton MA; Gibb GM; Yates A; Anderton BH
J Neurochem; 1997 Apr; 68(4):1736-44. PubMed ID: 9084448
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.
Ojala JO; Sutinen EM; Salminen A; Pirttilä T
J Neuroimmunol; 2008 Dec; 205(1-2):86-93. PubMed ID: 18947885
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
17. Ser
Sandhu P; Naeem MM; Lu C; Kumarathasan P; Gomes J; Basak A
Bioorg Med Chem Lett; 2017 Feb; 27(3):642-652. PubMed ID: 27989667
[TBL] [Abstract][Full Text] [Related]
18. Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer's Disease.
Austin SA; Katusic ZS
Circ Res; 2016 Oct; 119(10):1128-1134. PubMed ID: 27601478
[TBL] [Abstract][Full Text] [Related]
19. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
20. Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.
Gandini A; Bartolini M; Tedesco D; Martinez-Gonzalez L; Roca C; Campillo NE; Zaldivar-Diez J; Perez C; Zuccheri G; Miti A; Feoli A; Castellano S; Petralla S; Monti B; Rossi M; Moda F; Legname G; Martinez A; Bolognesi ML
J Med Chem; 2018 Sep; 61(17):7640-7656. PubMed ID: 30078314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
